How can policy makers and health care leaders ensure affordable, equitable access to GLP-1 medications while managing their ...

MIT engineers have designed a new method to improve the precision of gene therapy treatments by using gene circuits that ...

From enabling functional cures for genetic diseases to revolutionizing agriculture and biotechnology, CRISPR is poised to reshape global industries. The next decade will witness deeper integration of ...

Title: Characterization of KRIYA-839, an AAV-based Gene Therapy Providing Insulin and Glucokinase, in Streptozotocin-induced Diabetic Mice, B. Burch et al. (Poster Abstract 504) Date: May 13, 2025 ...

Sangamo Therapeutics, Inc. , a genomic medicine company, today announced that the American Society of Gene & Cell Therapy (ASGCT) has accepted nine Sangamo abstracts for presentation at the 28th ASGCT ...

Cross-species BBB-penetrant IV-delivered AAV gene therapy provides broad and robust CNS tau lowering in tauopathy mouse ...

Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its ...

As tariffs, HHS workforce cuts and the ouster of CBER Director Peter Marks threaten the “lifeblood” of the cell and gene ...

Historically, small molecule drugs have been precisely designed down to the atomic scale. Considering their relatively large complex structures, nanomedicines have lagged behind. Researchers argue ...

What if business leaders approached strategy the way scientists design gene delivery vectors? In biotechnology, precision, ...